Single-cell transcriptomic and spatial transcriptomic techniques can be used to study the heterogeneities and orchestration between STIE and TIME, before and after treatment with PD-1 inhibitors, the impacts of metabolic neural pathways on TIME, their overall influences on the immune microenvironment, and individual effect of traditional cancer treatment like immune modulating radiotherapy. Here, PDCD1 is linked to cancer.